ConductScience.org, home

Paper10691292

Anandamides inhibit binding to the muscarinic acetylcholine receptor.

Lagalwar S and 4 others. J Mol Neurosci, 1999. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anandamides inhibit binding to the muscarinic acetylcholine receptor. Papers, record 10691292. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691292

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anandamides inhibit binding to the muscarinic acetylcholine receptor.
PubMed
Journal
J Mol Neurosci
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2026-10-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lagalwar SS
2Bordayo EZE Z
3Hoffmann KLK L
4Fawcett JRJ R
5Frey WH 2ndW H

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arachidonic AcidsMajor topic
Calcium Channel BlockersMajor topic
Receptors, MuscarinicMajor topic
Arachidonic Acid
Binding, Competitive
Endocannabinoids
Humans
Polyunsaturated Alkamides
Receptors, Cannabinoid
Receptors, Drug

Source PubMed

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,520,605Health aspects of cannabis.Pharmacol Rev1986https://conductscience.org/library/papers/3520605PubMed
26,245,205Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.J Pharmacol Exp Ther1980https://conductscience.org/library/papers/6245205PubMed
39,770,643Inhibition of antagonist and agonist binding to the human brain muscarinic receptor by arachidonic acid.J Mol Neurosci1998https://conductscience.org/library/papers/9770643PubMed
43,860,088A critical review of the role of the cholinergic system in human memory and cognition.Ann N Y Acad Sci1985https://conductscience.org/library/papers/3860088PubMed
54,670,597Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats.Neuropharmacology1972https://conductscience.org/library/papers/4670597PubMed
64,359,364Human memory and the cholinergic system. A relationship to aging?Arch Neurol1974https://conductscience.org/library/papers/4359364PubMed
75,447,045Marijuana and immediate memory.Nature1970https://conductscience.org/library/papers/5447045PubMed
89,295,197Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation.Brain Res1997https://conductscience.org/library/papers/9295197PubMed
93,529,128Cannabinoid pharmacology.Pharmacol Rev1986https://conductscience.org/library/papers/3529128PubMed
104,610,597Cannabis: neural mechanisms and behavior--a theoretical review.Pharmacology1974https://conductscience.org/library/papers/4610597PubMed
119,458,263Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid.J Lipid Res1997https://conductscience.org/library/papers/9458263PubMed
126,306,710Cannabis: effects on memory and the cholinergic limbic system.Psychol Bull1983https://conductscience.org/library/papers/6306710PubMed
137,812,767Inhibitor of antagonist binding to the muscarinic receptor is elevated in Alzheimer's brain.Brain Res1994https://conductscience.org/library/papers/7812767PubMed
147,155,123Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.Mol Pharmacol1982https://conductscience.org/library/papers/7155123PubMed
152,830,949The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro.Brain Res Bull1987https://conductscience.org/library/papers/2830949PubMed
169,262,477Functional role of high-affinity anandamide transport, as revealed by selective inhibition.Science1997https://conductscience.org/library/papers/9262477PubMed
172,847,172Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2847172PubMed
187,058,341Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.Science1982https://conductscience.org/library/papers/7058341PubMed
199,813,364Anandamide modulates sleep and memory in rats.Brain Res1998https://conductscience.org/library/papers/9813364PubMed
208,021,930(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.J Med Chem1994https://conductscience.org/library/papers/8021930PubMed

See all 27 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
39,056,330Melatonin attenuates scopolamine-induced cognitive dysfunction through SIRT1/IRE1α/XBP1 pathway.CNS Neurosci Ther2024https://conductscience.org/library/papers/39056330PubMed
36,538,202Inhibitory Action of Omega-3 and Omega-6 Fatty Acids Alpha-Linolenic, Arachidonic and Linoleic acid on Human Erythrocyte Acetylcholinesterase.Protein J2023https://conductscience.org/library/papers/36538202PubMed
36,338,493Effects of cannabinoids on ligand-gated ion channels.Front Physiol2022https://conductscience.org/library/papers/36338493PubMed
36,080,227New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.Molecules2022https://conductscience.org/library/papers/36080227PubMed
34,827,695Nanoscale Sub-Compartmentalization of the Dendritic Spine Compartment.Biomolecules2021https://conductscience.org/library/papers/34827695PubMed
32,065,105Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.Curr Neuropharmacol2020https://conductscience.org/library/papers/32065105PubMed
21,079,038International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.Pharmacol Rev2010https://conductscience.org/library/papers/21079038PubMed
20,166,927Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Curr Med Chem2010https://conductscience.org/library/papers/20166927PubMed
16,186,629Inhibition of ligand binding to G protein-coupled receptors by arachidonic acid.J Mol Neurosci2005https://conductscience.org/library/papers/16186629PubMed
11,831,553Cannabinoids and neuroprotection.Mol Neurobiol2001https://conductscience.org/library/papers/11831553PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10691292

GET https://conductscience.org/api/papers/v1/10691292/references?page=2